MARINELLI, DANIELE
MARINELLI, DANIELE
DIPARTIMENTO DI MEDICINA SPERIMENTALE
11P Reconstructing tumour evolution of single cells using both somatic mutations and copy-number alterations
2023 Zaidi, R.; Ward, S.; Bunkum, A.; Lucas, O. J.; Hill, M.; Marinelli, D.; Lombardelli, C.; Swanton, C.; Jamal-Hanjani, M.; Zaccaria, S.
127P {RAS}, {RAF} and {NF}1 oncogenic mutations in {KRAS}-mutated lung adenocarcinoma
2022 Marinelli, D.; Pisegna, S.; Chiavassa, A.; Bengala, E.; Capasso, C.; Sabatini, A.; Ciurluini, F.; Artemi, A.; Torchia, A.; Gallina, F. T.; Botticelli, A.; Gazzaniga, P.; Cortesi, E.; Gelibter, A. J.
167P Molecular analysis of gastrointestinal stromal tumor (GIST): The experience of Regina Elena National Cancer Institute
2023 Torchia, A.; Casini, B.; Marinelli, D.; Cerro, M.; Maccallini, M. T.; Riva, F.; Covello, R.; Carpano, S.; Russillo, M.; Ceddia, S.; Onesti, C. E.; Vari, S.; Ferraresi, V.
3MO Oncogenic non-G12C {KRAS} mutations in {KRAS} G12C mutated lung adenocarcinomas in {TRACERx} and {GENIE}: A reservoir for intrinsic resistance to {KRAS} G12C inhibitors
2021 Marinelli, D.; Pisegna, S.; Giammaruco, M.; Chesi, P.; Mammone, G.; Ceddia, S.; Gazzaniga, P.; Cortesi, E.; Gelibter, A. J.
56P The prognostic role of {KRAS} mutations in patients with early-stage lung adenocarcinoma after robotic lobectomy and systematic lymphadenectomy
2022 Gallina, F. T.; Marinelli, D.; Forcella, D.; Taj(`(e)), R.; Ceddia, S.; Fusco, F.; Melis, E.; Buglioni, S.; Visca, P.; Cappuzzo, F.; Facciolo, F.
86P {KRAS} G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma
2023 Marinelli, D.; Melis, E.; Torchia, A.; Forcella, D.; Botticelli, A.; Visca, P.; Buglioni, S.; Facciolo, F.; Gallina, F. T.
Abstract PR010: Linking proliferation rate to the evolution of single-cell primary and metastatic tumor clones
2024 Lucas, Olivia; Ward, Sophia; Zaidi, Rija; Bunkum, Abigail; Frankell, Alexander M.; Moore, David A.; Hill, Mark S.; Liu, Wing Kin; Marinelli, Daniele; Lim, Emilia L.; Hessey, Sonya; Naceur-Lombardelli, Cristina; Rowan, Andrew; Mann, Sukhveer; Zhai, Haoran; Dietzen, Michelle; Ding, Boyue; Royle, Gary; Mcgranahan, Nicholas; Jamal-Hanjani, Mariam; Kanu, Nnennaya; Swanton, Charles; Zaccaria, Simone
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease
2022 Metro, Giulio; De Giglio, Andrea; Ricciuti, Biagio; Siringo, Marco; Marinelli, Daniele; Gelibter, Alain; Pecci, Federica; Berardi, Rossana; Cantini, Luca; Di Federico, Alessandro; Andrini, Elisa; Mosca, Mirta; Lamberti, Giuseppe; Brambilla, Marta; Mountzios, Giannis
Analysis of molecular biomarkers in resected early-stage non-small cells lung cancer: a narrative review
2022 Gallina, F. T.; Bertolaccini, L.; Forcella, D.; Mohamed, S.; Ceddia, S.; Melis, E.; Fusco, F.; Bardoni, C.; Marinelli, D.; Buglioni, S.; Visca, P.; Cappuzzo, F.; Spaggiari, L.; Facciolo, F.
Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC
2023 Gallina, Filippo Tommaso; Marinelli, Daniele; Tajè, Riccardo; Forcella, Daniele; Alessandrini, Gabriele; Cecere, Fabiana Letizia; Fusco, Francesca; Visca, Paolo; Sperduti, Isabella; Ambrogi, Vincenzo; Cappuzzo, Federico; Melis, Enrico; Facciolo, Francesco
Burnout of health care providers during the covid-19 pandemic: Focus on medical oncologists
2021 Vici, P.; Krasniqi, E.; Pizzuti, L.; Ciliberto, G.; Mazzotta, M.; Marinelli, D.; Barba, M.
CDKN2A/B gene loss and MDM2 alteration as a potential molecular signature for hyperprogressive disease in advanced NSCLC: A next-generation-sequencing approach
2019 Giusti, Raffaele; Mazzotta, Marco; Filetti, Marco; Marinelli, Daniele; Di Napoli, Arianna; Scarpino, Stefania; Scafetta, Giorgia; Mei, Monica; Vecchione, Andrea; Ruco, Luigi; Marchetti, Paolo
Characterizing the evolutionary dynamics of cancer proliferation in single-cell clones with SPRINTER
2024 Lucas, Olivia; Ward, Sophia; Zaidi, Rija; Bunkum, Abigail; Frankell, Alexander M; Moore, David A; Hill, Mark S; Liu, Wing Kin; Marinelli, Daniele; Lim, Emilia L; Hessey, Sonya; Naceur-Lombardelli, Cristina; Rowan, Andrew; Purewal-Mann, Sukhveer Kaur; Zhai, Haoran; Dietzen, Michelle; Ding, Boyue; Royle, Gary; Aparicio, Samuel; Mcgranahan, Nicholas; Jamal-Hanjani, Mariam; Kanu, Nnennaya; Swanton, Charles; Zaccaria, Simone
Circulating hpv dna in the management of oropharyngeal and cervical cancers: current knowledge and future perspectives
2021 Krasniqi, E.; Barba, M.; Venuti, A.; Pizzuti, L.; Cappuzzo, F.; Landi, L.; Carpano, S.; Marchetti, P.; Villa, A.; Vizza, E.; Giuliano, G.; Mazzotta, M.; Marinelli, D.; Gnignera, S.; Vincenzoni, C.; Stranges, V.; Sergi, D.; Giordano, A.; Tomao, F.; Maugeri-Sacca, M.; Sanguineti, G.; Di Lisa, F. S.; Tomao, S.; Ciliberto, G.; Vici, P.
Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence
2017 Caponnetto, S.; Gelibter, A.; Mosillo, C.; Magri, V.; Scagnoli, S.; Pomati, G.; Piesco, G.; Verkhovskaya, S.; Pisegna, S.; Sirgiovanni, G.; Napoli, V.; Buscicchio, D.; Iannantuono, G. M.; Marinelli, D.; Mammone, G.; Pannunzio, S.; Nicolo', E.; Stefani, A.; Astorino, V.; Mancini, M.; Cortesi, E.
Comparison of two blood-based genotyping tests to investigate the KRAS G12C mutation in patients with non-small-cell lung cancer at failure of first-line treatments
2021 Nicolazzo, Chiara; Gelibter, Alain; Bottillo, Irene; Belardinilli, Francesca; Pisegna, Simona; De Renzi, Gianluigi; Marinelli, Daniele; Grammatico, Paola; Cortesi, Enrico; Giannini, Giuseppe; Gazzaniga, Paola
Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis
2024 Cirillo, Alessio; Marinelli, Daniele; Romeo, Umberto; Messineo, Daniela; De Felice, Francesca; De Vincentiis, Marco; Valentini, Valentino; Mezi, Silvia; Valentini, Filippo; Vivona, Luca; Chiavassa, Antonella; Cerbelli, Bruna; Santini, Daniele; Bossi, Paolo; Polimeni, Antonella; Marchetti, Paolo; Botticelli, Andrea
COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience
2021 Barba, M.; Krasniqi, E.; Pizzuti, L.; Mazzotta, M.; Marinelli, D.; Giuliano, G.; Di Liso, F. S.; Cappuzzo, F.; Landi, L.; Tomao, S.; Ciliberto, G.; Vici, P.
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes
2020 Mazzotta, M.; Filetti, M.; Occhipinti, M.; Marinelli, D.; Scalera, S.; Terrenato, I.; Sperati, F.; Pallocca, M.; Rizzo, F.; Gelibter, A.; Botticelli, A.; Scafetta, G.; Di Napoli, A.; Krasniqi, E.; Pizzuti, L.; Barba, M.; Carpano, S.; Vici, P.; Fanciulli, M.; De Nicola, F.; Ciuffreda, L.; Goeman, F.; De Maria, R.; Vecchione, A.; Giusti, R.; Ciliberto, G.; Marchetti, P.; Maugeri-Sacca, M.
Immunotherapy-Based Combinations in First-Line Urothelial Cancer: A Systematic Review and Individual Patient Data (IPD) Meta-Analysis
2024 Di Civita, M. A.; Torchia, A.; Santini, D.; Marinelli, D.; Magro, V.; Cerro, M.; Pappalardo, L.; Maltese, G.; Santamaria, F.; Zacco, L.; Buccilli, D.; Dehghanpour, A.; Speranza, I.; Sciarra, A.; Panebianco, V.; Roberto, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 11P Reconstructing tumour evolution of single cells using both somatic mutations and copy-number alterations | 2023 | Zaidi, R.; Ward, S.; Bunkum, A.; Lucas, O. J.; Hill, M.; Marinelli, D.; Lombardelli, C.; Swanton, C.; Jamal-Hanjani, M.; Zaccaria, S. | |
| 127P {RAS}, {RAF} and {NF}1 oncogenic mutations in {KRAS}-mutated lung adenocarcinoma | 2022 | Marinelli, D.; Pisegna, S.; Chiavassa, A.; Bengala, E.; Capasso, C.; Sabatini, A.; Ciurluini, F.; Artemi, A.; Torchia, A.; Gallina, F. T.; Botticelli, A.; Gazzaniga, P.; Cortesi, E.; Gelibter, A. J. | |
| 167P Molecular analysis of gastrointestinal stromal tumor (GIST): The experience of Regina Elena National Cancer Institute | 2023 | Torchia, A.; Casini, B.; Marinelli, D.; Cerro, M.; Maccallini, M. T.; Riva, F.; Covello, R.; Carpano, S.; Russillo, M.; Ceddia, S.; Onesti, C. E.; Vari, S.; Ferraresi, V. | |
| 3MO Oncogenic non-G12C {KRAS} mutations in {KRAS} G12C mutated lung adenocarcinomas in {TRACERx} and {GENIE}: A reservoir for intrinsic resistance to {KRAS} G12C inhibitors | 2021 | Marinelli, D.; Pisegna, S.; Giammaruco, M.; Chesi, P.; Mammone, G.; Ceddia, S.; Gazzaniga, P.; Cortesi, E.; Gelibter, A. J. | |
| 56P The prognostic role of {KRAS} mutations in patients with early-stage lung adenocarcinoma after robotic lobectomy and systematic lymphadenectomy | 2022 | Gallina, F. T.; Marinelli, D.; Forcella, D.; Taj(`(e)), R.; Ceddia, S.; Fusco, F.; Melis, E.; Buglioni, S.; Visca, P.; Cappuzzo, F.; Facciolo, F. | |
| 86P {KRAS} G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma | 2023 | Marinelli, D.; Melis, E.; Torchia, A.; Forcella, D.; Botticelli, A.; Visca, P.; Buglioni, S.; Facciolo, F.; Gallina, F. T. | |
| Abstract PR010: Linking proliferation rate to the evolution of single-cell primary and metastatic tumor clones | 2024 | Lucas, Olivia; Ward, Sophia; Zaidi, Rija; Bunkum, Abigail; Frankell, Alexander M.; Moore, David A.; Hill, Mark S.; Liu, Wing Kin; Marinelli, Daniele; Lim, Emilia L.; Hessey, Sonya; Naceur-Lombardelli, Cristina; Rowan, Andrew; Mann, Sukhveer; Zhai, Haoran; Dietzen, Michelle; Ding, Boyue; Royle, Gary; Mcgranahan, Nicholas; Jamal-Hanjani, Mariam; Kanu, Nnennaya; Swanton, Charles; Zaccaria, Simone | |
| Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease | 2022 | Metro, Giulio; De Giglio, Andrea; Ricciuti, Biagio; Siringo, Marco; Marinelli, Daniele; Gelibter, Alain; Pecci, Federica; Berardi, Rossana; Cantini, Luca; Di Federico, Alessandro; Andrini, Elisa; Mosca, Mirta; Lamberti, Giuseppe; Brambilla, Marta; Mountzios, Giannis | |
| Analysis of molecular biomarkers in resected early-stage non-small cells lung cancer: a narrative review | 2022 | Gallina, F. T.; Bertolaccini, L.; Forcella, D.; Mohamed, S.; Ceddia, S.; Melis, E.; Fusco, F.; Bardoni, C.; Marinelli, D.; Buglioni, S.; Visca, P.; Cappuzzo, F.; Spaggiari, L.; Facciolo, F. | |
| Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC | 2023 | Gallina, Filippo Tommaso; Marinelli, Daniele; Tajè, Riccardo; Forcella, Daniele; Alessandrini, Gabriele; Cecere, Fabiana Letizia; Fusco, Francesca; Visca, Paolo; Sperduti, Isabella; Ambrogi, Vincenzo; Cappuzzo, Federico; Melis, Enrico; Facciolo, Francesco | |
| Burnout of health care providers during the covid-19 pandemic: Focus on medical oncologists | 2021 | Vici, P.; Krasniqi, E.; Pizzuti, L.; Ciliberto, G.; Mazzotta, M.; Marinelli, D.; Barba, M. | |
| CDKN2A/B gene loss and MDM2 alteration as a potential molecular signature for hyperprogressive disease in advanced NSCLC: A next-generation-sequencing approach | 2019 | Giusti, Raffaele; Mazzotta, Marco; Filetti, Marco; Marinelli, Daniele; Di Napoli, Arianna; Scarpino, Stefania; Scafetta, Giorgia; Mei, Monica; Vecchione, Andrea; Ruco, Luigi; Marchetti, Paolo | |
| Characterizing the evolutionary dynamics of cancer proliferation in single-cell clones with SPRINTER | 2024 | Lucas, Olivia; Ward, Sophia; Zaidi, Rija; Bunkum, Abigail; Frankell, Alexander M; Moore, David A; Hill, Mark S; Liu, Wing Kin; Marinelli, Daniele; Lim, Emilia L; Hessey, Sonya; Naceur-Lombardelli, Cristina; Rowan, Andrew; Purewal-Mann, Sukhveer Kaur; Zhai, Haoran; Dietzen, Michelle; Ding, Boyue; Royle, Gary; Aparicio, Samuel; Mcgranahan, Nicholas; Jamal-Hanjani, Mariam; Kanu, Nnennaya; Swanton, Charles; Zaccaria, Simone | |
| Circulating hpv dna in the management of oropharyngeal and cervical cancers: current knowledge and future perspectives | 2021 | Krasniqi, E.; Barba, M.; Venuti, A.; Pizzuti, L.; Cappuzzo, F.; Landi, L.; Carpano, S.; Marchetti, P.; Villa, A.; Vizza, E.; Giuliano, G.; Mazzotta, M.; Marinelli, D.; Gnignera, S.; Vincenzoni, C.; Stranges, V.; Sergi, D.; Giordano, A.; Tomao, F.; Maugeri-Sacca, M.; Sanguineti, G.; Di Lisa, F. S.; Tomao, S.; Ciliberto, G.; Vici, P. | |
| Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence | 2017 | Caponnetto, S.; Gelibter, A.; Mosillo, C.; Magri, V.; Scagnoli, S.; Pomati, G.; Piesco, G.; Verkhovskaya, S.; Pisegna, S.; Sirgiovanni, G.; Napoli, V.; Buscicchio, D.; Iannantuono, G. M.; Marinelli, D.; Mammone, G.; Pannunzio, S.; Nicolo', E.; Stefani, A.; Astorino, V.; Mancini, M.; Cortesi, E. | |
| Comparison of two blood-based genotyping tests to investigate the KRAS G12C mutation in patients with non-small-cell lung cancer at failure of first-line treatments | 2021 | Nicolazzo, Chiara; Gelibter, Alain; Bottillo, Irene; Belardinilli, Francesca; Pisegna, Simona; De Renzi, Gianluigi; Marinelli, Daniele; Grammatico, Paola; Cortesi, Enrico; Giannini, Giuseppe; Gazzaniga, Paola | |
| Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis | 2024 | Cirillo, Alessio; Marinelli, Daniele; Romeo, Umberto; Messineo, Daniela; De Felice, Francesca; De Vincentiis, Marco; Valentini, Valentino; Mezi, Silvia; Valentini, Filippo; Vivona, Luca; Chiavassa, Antonella; Cerbelli, Bruna; Santini, Daniele; Bossi, Paolo; Polimeni, Antonella; Marchetti, Paolo; Botticelli, Andrea | |
| COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience | 2021 | Barba, M.; Krasniqi, E.; Pizzuti, L.; Mazzotta, M.; Marinelli, D.; Giuliano, G.; Di Liso, F. S.; Cappuzzo, F.; Landi, L.; Tomao, S.; Ciliberto, G.; Vici, P. | |
| Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes | 2020 | Mazzotta, M.; Filetti, M.; Occhipinti, M.; Marinelli, D.; Scalera, S.; Terrenato, I.; Sperati, F.; Pallocca, M.; Rizzo, F.; Gelibter, A.; Botticelli, A.; Scafetta, G.; Di Napoli, A.; Krasniqi, E.; Pizzuti, L.; Barba, M.; Carpano, S.; Vici, P.; Fanciulli, M.; De Nicola, F.; Ciuffreda, L.; Goeman, F.; De Maria, R.; Vecchione, A.; Giusti, R.; Ciliberto, G.; Marchetti, P.; Maugeri-Sacca, M. | |
| Immunotherapy-Based Combinations in First-Line Urothelial Cancer: A Systematic Review and Individual Patient Data (IPD) Meta-Analysis | 2024 | Di Civita, M. A.; Torchia, A.; Santini, D.; Marinelli, D.; Magro, V.; Cerro, M.; Pappalardo, L.; Maltese, G.; Santamaria, F.; Zacco, L.; Buccilli, D.; Dehghanpour, A.; Speranza, I.; Sciarra, A.; Panebianco, V.; Roberto, M. |